ERBB2 and breast cancer: The current review deepens and expands our knowledge of anti-breast cancer activity of curcumin by interfering with these oncogenic signaling pathways, which leads to the regulation of cell survival and proliferation, metastasis, angiogenesis, cancer stem cell, and cell death in TNBC and hormone-independent HER2+ breast cancer.